Stopped: Funding was withdrawn
The purpose of this trial is to study the effectiveness of the AprictyRxTM care service to improve treatment outcomes of ethnic/racial minority N.S.C.L.C. patients receiving standard of care immunotherapy, and reduce the frequency of healthcare system interactions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Likert-type scale score
Timeframe: 2 years
Percent of study patients who experienced treatment delay/discontinuation
Timeframe: 2 years